,

LNA-C(5-Me)(Bz) Co-Polymer Coated CPG

¥0.00

Product NameLNA-C(5-Me)(Bz) Co-Polymer Coated CPG
Available Format5′-O-DMT-LNA-5-Me-dC(Bz)-3′-succinoyl-LCAA-CPG
Support TypeCo-Polymer Coated CPG for incorporation of a 5-methyl-locked nucleic acid C analogue at the 3′ end of an oligonucleotide
Supply FormatAvailable as Bulk CPG Powder or Pre-packed Synthesis Columns
ApplicationHigh-affinity, low-immunogenicity antisense oligonucleotides (ASOs), siRNA, and diagnostic gapmers synthesis
Pore Size Options500 Å / 1000 Å / 2000 Å
Loading Capacity500 Å: 200–240 μmol/g
1000 Å: 90–100 μmol/g
2000 Å: 50–80 μmol/g
Storage ConditionsStore at -20°C, keep dry, desiccated, and tightly sealed
Pack Size500mg, 1g, 2g, Custom Pack (Bulk configurations available)
Support CompatibilityCompatible with Hyper-link Co-polymer Coated CPG platforms and high-affinity LNA synthesis workflows.
Request a Quote

LNA-C(5-Me)(Bz) Co-Polymer Coated CPG

Product Overview

LNA-C(5-Me)(Bz) Co-Polymer Coated CPG is an advanced, premium-grade solid support matrix engineered for automated oligonucleotide synthesis. This specialized product is optimized for the seamless incorporation of a 5-methyl-locked nucleic acid C [LNA-C(5-Me)] analogue at the 3′ end of an oligonucleotide sequence.

Featuring N⁴-benzoyl (Bz) protection on the cytidine nucleobase along with a strategic 5-methyl modification, this modified solid support allows for highly efficient chain elongation using standard DNA or RNA phosphoramidite chemistries. The incorporation of 5-Me-LNA-C residues at the 3′ terminus conformationally locks the ribose ring in a strict 3′-endo structure, drastically enhancing duplex thermal stability ΔTm. Furthermore, the 5-methyl modification significantly reduces potential immune responses in vivo while providing exceptional protection against 3′-exonucleolytic degradation, making it an indispensable tool for designing high-performance antisense oligonucleotides (ASOs), siRNA, and gapmers.

Key Technical Features & Guidelines

  • Advanced 5-Methyl Modification: The 5-methyl groups further stabilize the duplex architecture and mitigate immune receptor recognition compared to unmodified cytidine analogues.

  • Targeted 3′-End LNA Incorporation: Optimized specifically for solid-phase placement of an $N^4$-benzoyl protected 5-Me-LNA-C analogue at the 3′ terminus.

  • Elevated Duplex Stability: Maximizes binding affinity toward complementary RNA or DNA strands, allowing precise thermodynamic tuning of synthetic therapeutic sequences.

  • Advanced Co-Polymer Coating: Our proprietary crosslinked co-polymer surface chemistry eliminates silica contamination and prevents swelling, ensuring stable column pressure and reproducible fluidic flow rates under automated cycle runs.

  • Standardized Protection Profile: The benzoyl protection group is fully compatible with conventional downstream deprotection protocols (e.g., concentrated ammonia or AMA), fitting seamlessly into existing DNA/RNA synthesis workflows.

  • Flexible Pore Size Infrastructure: Available in 500 Å, 1000 Å, and 2000 Å pore sizes to comfortably accommodate both high-throughput diagnostic custom scales and heavily mass-loaded therapeutic scalability.

Applications

  • High-Affinity & Low-Immunogenicity Therapeutics: Fabrication of next-generation ASOs, siRNA candidates, and anti-miRNA oligonucleotides requiring minimized immune activation and robust 3′-end capping.

  • Thermodynamically Tuned Probes: Production of dual-labeled diagnostic probes and gapmers where precise $T_m$ control is critical.

  • Nuclease-Resistant Nucleic Acids: Custom engineering of oligonucleotides intended for extended stability in serum or cellular environments.

Synthesis Optimization Note (Hyper-link CPG Benefits)

Our LNA-C(5-Me)(Bz) CPG product line leverages our proprietary co-polymer coated matrix technology (Hyper-link CPG), which is available for all kinds of tailored linkers. This structural integration unlocks measurable benefits for industrial scale-up:

  • 3× Higher Output & Lower COG: Our Hyper-link CPG delivers up to a 3× higher loading capacity compared to traditional corresponding un-coated supports, allowing laboratories to drastically lower their overall Cost of Goods (COG).

  • ~30% Lower Purification Costs: Delivers exceptional Full-Length Product (FLP) purity straight out of the synthesis column, optimizing downstream chromatographic workflows.

  • Reliable Long-Oligo Synthesis: Engineered to sustain high coupling efficiency for complex or extended sequences (100–300 nt) with zero structural collapse.

We supply this product as a standalone, high-performance solid support matrix in multiple bulk configurations to meet your specific research and commercial production scales.

Related Products:

LNA-T CPG Co-Polymer Coated

LNA-G(dmf) Co-Polymer Coated CPG

LNA-C(Bz) Co-Polymer Coated CPG

LNA-A(Bz) Co-Polymer Coated CPG

Base

CAS Number

Form

,

Modification

,

Protection Group

, ,

Pore Size

, , ,

Reactive Group

Purity

Storage

-20°C, Dry

Reviews

There are no reviews yet.

Be the first to review “LNA-C(5-Me)(Bz) Co-Polymer Coated CPG”

Your email address will not be published. Required fields are marked *

Scroll to Top